Integration of nanotechnology in triple negative breast cancer research: a bibliometric and emerging trends analysis
Further research into ferroptosis-based therapy for TNBC, immunogenic cell death (ICD) with nano-enabled immunotherapy, multimodal nanotheranostics for TNBC, and clinical translation of NT in TNBC studies is recommended to advance nanotechnology research in TNBC.
Authors
- Daniel Thakuma Tizhe (ORCID: https://orcid.org/0000-0002-2661-0603)
- Shadrack Dangabar Apollos (ORCID: https://orcid.org/0009-0005-3915-8811)
- Wadzani Palnam Dauda (ORCID: https://orcid.org/0000-0002-5233-0058)
- Emohchonne Utos Jonathan (ORCID: https://orcid.org/0000-0002-8576-8910)
- Jeremiah Zaphnathpaaneah Adaji
- Faustina Ntim Opoku
- Kodjovi Sossou
- Eneh Philip
- Samson Usman
- Israel Ogwuche Ogra
Institutions
- University of Nigeria (NG)
- Ahmadu Bello University (NG)
- Federal University of Agriculture, Abeokuta (NG)
- National Research Tomsk State University (RU)
- Tomsk Polytechnic University (RU)
- Kwararafa University (NG)
- University of Lomé (TG)
- Modibbo Adama University of Technology (NG)
Publication Details
- Journal
- Discover Nano
- Published
- 2026-03-17
- DOI
- https://doi.org/10.1186/s11671-026-04510-z
- Primary Topic
- Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00